Analytik Jena AG Acquires UVP, LLC
News Apr 02, 2013
Analytik Jena AG has with the approval of the Supervisory Board signed a contract for the acquisition of all shares of UVP, LLC, incorporated under US law as a limited liability company, based in Upland/California, USA. Upon the transfer of the shares for purposes of the closing of this transaction, which is scheduled for April 5, 2013, Analytik Jena AG acquires besides the UVP, LLC also its wholly owned subsidiary, Ultra-Violet Products Ltd., based in Cambridge, Great Britain. The parties have agreed not to reveal the purchase price.
The UVP group generated sales of around USD 17.2 m in the past financial year 2012 and has 109 employees worldwide. Almost half of the sales are generated in North America. The company operates its business already since 1932.
By integrating UVP, LLC into the Analytik Jena Group a significant increase of the revenue and earnings figures of the Life Science business unit as well as numerous synergies are expected. The Company aims to reach an operating result (EBIT) above breakeven in this unit already for the 2nd half of financial year 2012/2013 and expects for the financial year 2013/2014 (which begins in October) sales above EUR 40.0 m and operating earnings of 4.0 % to 7.0 %. Alongside the expansion and rounding off of the product portfolio, Analytik Jena plans with this acquisition to enter the US market with the products of the Life Science business unit.
Cancer Gene Plays Key Role in Cystic Fibrosis Lung InfectionsNews
Recent findings explain why people with cystic fibrosis are particularly prone to respiratory infections—and suggest a new approach to treatment.READ MORE
Exploring African Genetic Diversity Unlocks Disease Susceptibility TraitsNews
African populations harbour the greatest genetic diversity and have the highest per capita health burden, yet they are rarely included in large genome studies of disease association, the authors of this study want to change this fact.READ MORE
IDEX Health & Science Announces Acquisition of New Microfluidics CompanyNews
IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.READ MORE